Xiaosu Ma

1.1k citations
22 papers · 670 · 4 hit papers · h-index 10

Impact in

Papers in

    • Diabetes Treatment and Management 15
    • Diabetes Management and Research 7
    • Diabetes, Cardiovascular Risks, and Lipoproteins 3
    • Pancreatic function and diabetes 5
    • Bariatric Surgery and Outcomes 3

Xiaosu Ma

19 papers receiving 658 citations

Xiaosu Ma's Hit Papers

Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial 2025 · 16 citations
160+1+2Years since publication50100150200250

Peers

Xiaosu Ma
Comparison fields: 5 of 68
  • Endocrinology, Diabetes and Metabolism 451
  • Pharmacology 219
  • Surgery 227
  • Physiology 132
  • Cardiology and Cardiovascular Medicine 74
Replace Christof Kazda with:
Christof Kazda United States
Christopher Sorli United States
Ted Okerson United States
Günaj Rakipovski Denmark
Marilyn K. Boardman United States
Mario Widel United States
Julie Derving Karsbøl Denmark
Fred Yang United States
Ivano Franzetti Italy
Jorma Strand Finland
Xiaosu Ma relative to Christof Kazda United States Christof Kazda's profile →
Citations per field
00.5×1.5×2.2×
Christof Kazda · 1×
Citations per year

Countries citing papers authored by Xiaosu Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaosu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosu Ma more than expected).

Fields of papers citing papers by Xiaosu Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaosu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosu Ma. The network helps show where Xiaosu Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaosu Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaosu Ma Line = papers co-authored together Xiaosu Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Hit paper breakdown →
2023259
2
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
Hit paper breakdown →
2023124
3
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
Hit paper breakdown →
202397
4 202334
5 201428
6 202323
7 202221
8 200917
9
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
202516
10 202412
11 20158
12 20248
13 20198
14 20194
15 20254
16 20202
17 20172
18 20072
19 20251
20 20250

About Xiaosu Ma

Xiaosu Ma is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology, having authored 22 papers that have together received 670 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (7 papers), Pancreatic function and diabetes (5 papers), Pharmacology and Obesity Treatment (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Bariatric Surgery and Outcomes (3 papers) and Gestational Diabetes Research and Management (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (451 citations), Pharmacology (219 citations), Surgery (227 citations), Physiology (132 citations) and Cardiology and Cardiovascular Medicine (74 citations). Xiaosu Ma has collaborated with scholars based in United States, Australia and Singapore. Frequent co-authors include Edward Pratt, Axel Haupt, Deborah A. Robins, Christof Kazda, Kieren J. Mather, Маниге Кониг, Julio Rosenstock, Rong Liu, Sean Wharton and Thomas Blevins. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Diabetes Obesity and Metabolism, The Journal of Clinical Pharmacology, The Lancet and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact